Johnson & Johnson is a global American pharmaceutical and consumer goods company with headquarters in New Brunswick, New Jersey. The company is listed in the Dow Jones Industrial Average.
P/E ratio for Johnson & Johnson (JNJ)
P/E ratio as of May 2024 (TTM): 10.7
According to Johnson & Johnson's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 10.736. At the end of 2022 the company had a P/E ratio of 25.9.
P/E ratio history for Johnson & Johnson from 2001 to 2023
PE ratio at the end of each year
| Year | P/E ratio | Change |
|---|---|---|
| 2022 | 25.9 | 19.85% |
| 2021 | 21.6 | -23.35% |
| 2020 | 28.2 | 33.07% |
| 2019 | 21.2 | -6.74% |
| 2018 | 22.7 | -92.46% |
| 2017 | 301 | 1460.23% |
| 2016 | 19.3 | 4.46% |
| 2015 | 18.5 | 2.49% |
| 2014 | 18.0 | -3.32% |
| 2013 | 18.6 | 4.62% |
| 2012 | 17.8 | -3.85% |
| 2011 | 18.5 | 45.08% |
| 2010 | 12.8 | -12.21% |
| 2009 | 14.5 | 12.32% |
| 2008 | 13.0 | -28.94% |
| 2007 | 18.2 | 3.79% |
| 2006 | 17.6 | -1.25% |
| 2005 | 17.8 | -22.81% |
| 2004 | 23.0 | 8.57% |
| 2003 | 21.2 | -13.1% |
| 2002 | 24.4 | -23.17% |
| 2001 | 31.8 |
P/E ratio for similar companies or competitors
| Company | P/E ratio | P/E ratio differencediff. | Country |
|---|---|---|---|
 Novartis NVS | 27.3 | 154.68% | 🇨🇭 Switzerland |
 Pfizer PFE | 15.3 | 42.42% | 🇺🇸 USA |
 Abbott Laboratories ABT | 35.3 | 228.33% | 🇺🇸 USA |
 Medtronic MDT | 30.7 | 186.01% | 🇮🇪 Ireland |
 Eli Lilly LLY | 140 | 1,199.91% | 🇺🇸 USA |
 Sanofi SNY | 15.8 | 47.06% | 🇫🇷 France |
 Gilead Sciences GILD | 15.4 | 43.30% | 🇺🇸 USA |
 Stryker Corporation SYK | 47.7 | 343.92% | 🇺🇸 USA |
 Merck MRK | 71.0 | 561.07% | 🇺🇸 USA |
 GlaxoSmithKline GSK | 12.9 | 20.19% | 🇬🇧 UK |
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.